Cargando…

Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report

INTRODUCTION: A patient undergoing hemodialysis and being treated with everolimus for metastatic epithelioid angiomyolipoma has never been described in the literature, to our knowledge. CASE PRESENTATION: A 53‐year‐old woman who had undergone trans‐arterial embolization for epithelioid angiomyolipom...

Descripción completa

Detalles Bibliográficos
Autores principales: Takai, Manabu, Kameyama, Koji, Toyota, Shohei, Kamei, Shingo, Yokoi, Shigeaki, Ishihara, Satoshi, Deguchi, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292099/
https://www.ncbi.nlm.nih.gov/pubmed/32743437
http://dx.doi.org/10.1002/iju5.12103
Descripción
Sumario:INTRODUCTION: A patient undergoing hemodialysis and being treated with everolimus for metastatic epithelioid angiomyolipoma has never been described in the literature, to our knowledge. CASE PRESENTATION: A 53‐year‐old woman who had undergone trans‐arterial embolization for epithelioid angiomyolipoma was referred with a chief complaint about right knee pain. Hemodialysis had been started after the embolization. Needle biopsy specimens of tumors obtained from behind the right kidney and in the right femur were diagnosed as epithelioid angiomyolipoma metastases. The patient underwent treatment with everolimus and achieved a partial response after 6 months of treatment without serious adverse events. CONCLUSION: Everolimus might be effective for patients with metastatic epithelioid angiomyolipoma who are undergoing hemodialysis.